Most events are mild to moderate, occur during escalation, and diminish over time
Technically, injecting into this fat layer would deliver the medication to the correct depth
Studies show that 50 to 60 percent of lost weight returns within a year of stopping GLP-1 without a maintenance plan
Other agents like liraglutide, exenatide, and oral formulations such as orforglipron produce smaller but still meaningful reductions
doi: 10.3389/fimmu.2024.1466023 Received 17 July 2024 Accepted 09 September 2024 Published 25 September 2024 Volume 15 - 2024 Edited by Reza Akbarzadeh, University of Lbeck, Germany Reviewed by Maximiliano Jimenez Dalmaroni, National University of La Plata, Argentina Bernhard Ryffel, Centre National de la Recherche Scientifique (CNRS), France Jrmie Decalf, Genentech Inc., United States Updates Copyright 2024 Zhu and Zhou